Sgi Q4 Earnings Misses Estimates By 0.01 20260403 T Stamp IDAI Q1 2026 Earnings EPS Miss Widens as Revenue Details Remain Undisclosed ECCX Q1 2026 Earnings Slight EPS Miss Amid Stable Distribution Performance TPST Q1 2026 Earnings Deep EPS Miss Highlights ClinicalStage Biotech Challenges Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises Community Health Systems Q1 2026 Earnings Significant EPS Miss Stock Gains on Operational Detail AGM Q1 2026 Earnings Strong EPS Beat Driven by Core Operations